scispace - formally typeset
H

Hironobu Tsukamoto

Researcher at Nagoya City University

Publications -  35
Citations -  541

Hironobu Tsukamoto is an academic researcher from Nagoya City University. The author has contributed to research in topics: Adalimumab & Infliximab. The author has an hindex of 13, co-authored 33 publications receiving 453 citations.

Papers
More filters
Journal ArticleDOI

Mechanisms of Cisplatin-Induced Apoptosis and of Cisplatin Sensitivity: Potential of BIN1 to Act as a Potent Predictor of Cisplatin Sensitivity in Gastric Cancer Treatment

TL;DR: A new mechanism has recently been revealed, in which the oncoprotein c-Myc suppresses bridging integrator 1 (BIN1), thereby releasing poly(ADP-ribose)polymerase 1, which results in increased DNA repair activity and allows cancer cells to acquire cisplatin resistance.
Journal ArticleDOI

Establishment of a long-term three-dimensional primary culture of mouse glandular stomach epithelial cells within the stem cell niche.

TL;DR: A long-term three-dimensional (3D) primary gastric culture system within the stem cell niche is described to investigate the role of signaling between cell-cell and epithelial-mesenchymal interactions in an environment that is extremely similar to the in vivo environment.